Chuah MK - Search Results

1

Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua.

Nair N, De Wolf D, Nguyen PA, Pham QH, Samara-Kuko E, Landau J, Blouse GE, Chuah MK, VandenDriessche T. Nair N, et al. Among authors: chuah mk. Blood. 2021 May 27;137(21):2902-2906. doi: 10.1182/blood.2020006005. Blood. 2021. PMID: 33735915 Free PMC article.

2

Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.

Chuah MK, VandenDriessche T, Chang HK, Ensoli B, Morgan RA. Chuah MK, et al. Hum Gene Ther. 1994 Dec;5(12):1467-75. doi: 10.1089/hum.1994.5.12-1467. Hum Gene Ther. 1994. PMID: 7711139

3

Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes.

VandenDriessche T, Chuah MK, Chiang L, Chang HK, Ensoli B, Morgan RA. VandenDriessche T, et al. Among authors: chuah mk. J Virol. 1995 Jul;69(7):4045-52. doi: 10.1128/JVI.69.7.4045-4052.1995. J Virol. 1995. PMID: 7769662 Free PMC article.

4

Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.

Chuah MK, VandenDriessche T, Morgan RA. Chuah MK, et al. Hum Gene Ther. 1995 Nov;6(11):1363-77. doi: 10.1089/hum.1995.6.11-1363. Hum Gene Ther. 1995. PMID: 8573610

5

Bone marrow stromal cells as targets for gene therapy of hemophilia A.

Chuah MK, Brems H, Vanslembrouck V, Collen D, VandenDriessche T. Chuah MK, et al. Hum Gene Ther. 1998 Feb 10;9(3):353-65. doi: 10.1089/hum.1998.9.3-353. Hum Gene Ther. 1998. PMID: 9508053

6

Anti-viral strategies.

Chuah MK, VandenDriessche T, Morgan RA. Chuah MK, et al. Mol Cell Biol Hum Dis Ser. 1995;5:175-94. doi: 10.1007/978-94-011-0547-7_10. Mol Cell Biol Hum Dis Ser. 1995. PMID: 9532567 Review. No abstract available.

7

Gene therapy for hemophilia: hopes and hurdles.

Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Crit Rev Oncol Hematol. 1998 Sep;28(3):153-71. doi: 10.1016/s1040-8428(98)00022-5. Crit Rev Oncol Hematol. 1998. PMID: 9793744 Review. No abstract available.

8

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.

VandenDriessche T, Vanslembrouck V, Goovaerts I, Zwinnen H, Vanderhaeghen ML, Collen D, Chuah MK. VandenDriessche T, et al. Among authors: chuah mk. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10379-84. doi: 10.1073/pnas.96.18.10379. Proc Natl Acad Sci U S A. 1999. PMID: 10468616 Free PMC article.

9

Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.

Chuah MK, Van Damme A, Zwinnen H, Goovaerts I, Vanslembrouck V, Collen D, VandenDriessche T. Chuah MK, et al. Hum Gene Ther. 2000 Mar 20;11(5):729-38. doi: 10.1089/10430340050015626. Hum Gene Ther. 2000. PMID: 10757352

10

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.

Jacquemin M, Lavend'homme R, Benhida A, Vanzieleghem B, d'Oiron R, Lavergne JM, Brackmann HH, Schwaab R, VandenDriessche T, Chuah MK, Hoylaerts M, Gilles JG, Peerlinck K, Vermylen J, Saint-Remy JM. Jacquemin M, et al. Among authors: chuah mk. Blood. 2000 Aug 1;96(3):958-65. Blood. 2000. PMID: 10910910 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page